Donavon Charles Hiss (D C Hiss)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Breast Cancer Cells

Epidermal Growth Factor Receptor

Endoplasmic Reticulum Stress

Top Venues

International journal of molecular sciences

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Beynon Abrahams, Anthonie Gerber, Donavon Charles Hiss
Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro. International journal of molecular sciences 25 (5) (2024)
Beynon Abrahams, Anthonie Gerber, Donavon Charles Hiss
Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro. International journal of molecular sciences 25 (5) (2024)
Beynon Abrahams, Anthonie Gerber, Donavon Charles Hiss
Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro. International journal of molecular sciences 25 (5) (2024)
Jelili A Badmus, Okobi Eko Ekpo, Ahmed A Hussein, Mervin Meyer, Donavon Charles Hiss
Corrigendum to "Antiproliferative and Apoptosis Induction Potential of the Methanolic Leaf Extract of Holarrhena floribunda (G. Don)". Evidence-based complementary and alternative medicine : eCAM 2020 (2020)